Patents by Inventor Simon Tulloch

Simon Tulloch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180082285
    Abstract: The disclosed technology addresses the need in the art for a mobile wallet application that can intelligently select a transaction based on a geographic region in which the card was issued, and in which a transaction is to take place. The present technology can determine a region where a transaction card was issued from, and designate the transaction card as the default card for the determined region, and can automatically select the card for use with transactions taking place in the determined region.
    Type: Application
    Filed: September 22, 2016
    Publication date: March 22, 2018
    Inventors: Alosious Pradeep Prabhakar, Alistair McFarlane, Mohammad Amin Malek, Simon Tulloch
  • Publication number: 20080113955
    Abstract: Methods of treating infant hyperbilirubinemia using stannsoporfin are disclosed. The methods of the invention permit treatment of various patient populations at lower doses of stannsoporfin than previously believed effective, providing advantages in therapeutic administration.
    Type: Application
    Filed: October 4, 2007
    Publication date: May 15, 2008
    Inventors: Benjamin LEVINSON, Simon Tulloch
  • Publication number: 20060094709
    Abstract: Carbamazepine, in extended release form, is useful in the treatment of patients suffering from bipolar disorder. In order to minimize the time it takes to reach efficacy, carbamazepine, in extended release form, can be administered to the patient at an initial daily dose which is then increased in daily increments until clinical efficacy is achieved.
    Type: Application
    Filed: December 14, 2005
    Publication date: May 4, 2006
    Inventors: Amir Kalali, Simon Tulloch
  • Publication number: 20050124601
    Abstract: Carbamazepine, in extended release form, is useful in the treatment of patients suffering from bipolar disorder. In order to minimize the time it takes to reach efficacy, carbamazepine, in extended release form, can be administered to the patient at an initial daily dose which is then increased in daily increments until clinical efficacy is achieved.
    Type: Application
    Filed: May 19, 2004
    Publication date: June 9, 2005
    Inventors: Amir Kalali, Simon Tulloch